Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Adenosine A1 receptor-mediated protection of mouse hippocampal synaptic transmission against oxygen and/or glucose deprivation: a comparative study.

Kawamura M Jr, Ruskin DN, Masino SA.

J Neurophysiol. 2019 Aug 1;122(2):721-728. doi: 10.1152/jn.00813.2018. Epub 2019 Jun 26.

PMID:
31242045
2.

Psychological and psychosocial interventions offered to forensic mental health inpatients: a systematic review.

MacInnes D, Masino S.

BMJ Open. 2019 Mar 20;9(3):e024351. doi: 10.1136/bmjopen-2018-024351.

3.

Dietary intervention for canine epilepsy: Two case reports.

Masino SA, Freedgood NR, Reichert HR, Director CJ, Whittemore VH, Zupec-Kania B.

Epilepsia Open. 2019 Feb 14;4(1):193-199. doi: 10.1002/epi4.12305. eCollection 2019 Mar.

4.

A ketogenic diet diminishes behavioral responses to cocaine in young adult male and female rats.

Martinez LA, Lees ME, Ruskin DN, Masino SA.

Neuropharmacology. 2019 May 1;149:27-34. doi: 10.1016/j.neuropharm.2019.02.001. Epub 2019 Feb 4.

PMID:
30731137
5.

Adenosine Signaling through A1 Receptors Inhibits Chemosensitive Neurons in the Retrotrapezoid Nucleus.

James SD, Hawkins VE, Falquetto B, Ruskin DN, Masino SA, Moreira TS, Olsen ML, Mulkey DK.

eNeuro. 2018 Dec 14;5(6). pii: ENEURO.0404-18.2018. doi: 10.1523/ENEURO.0404-18.2018. eCollection 2018 Nov-Dec.

6.

Ketogenic Diet Modulates NAD+-Dependent Enzymes and Reduces DNA Damage in Hippocampus.

Elamin M, Ruskin DN, Masino SA, Sacchetti P.

Front Cell Neurosci. 2018 Aug 30;12:263. doi: 10.3389/fncel.2018.00263. eCollection 2018.

7.

Metabolism and epilepsy: Ketogenic diets as a homeostatic link.

Masino SA, Rho JM.

Brain Res. 2019 Jan 15;1703:26-30. doi: 10.1016/j.brainres.2018.05.049. Epub 2018 Jun 6. Review.

PMID:
29883626
8.

Indigenous medicine and biomedical health care in fragile settings: insights from Burundi.

Falisse JB, Masino S, Ngenzebuhoro R.

Health Policy Plan. 2018 May 1;33(4):483-493. doi: 10.1093/heapol/czy002.

PMID:
29452365
9.

Ketone-Based Metabolic Therapy: Is Increased NAD+ a Primary Mechanism?

Elamin M, Ruskin DN, Masino SA, Sacchetti P.

Front Mol Neurosci. 2017 Nov 14;10:377. doi: 10.3389/fnmol.2017.00377. eCollection 2017.

10.

Editorial: Metabolic Control of Brain Homeostasis.

Boison D, Meier JC, Masino SA.

Front Mol Neurosci. 2017 Jun 9;10:184. doi: 10.3389/fnmol.2017.00184. eCollection 2017. No abstract available.

11.

Metabolic Dysfunction Underlying Autism Spectrum Disorder and Potential Treatment Approaches.

Cheng N, Rho JM, Masino SA.

Front Mol Neurosci. 2017 Feb 21;10:34. doi: 10.3389/fnmol.2017.00034. eCollection 2017. Review.

12.

Ketogenic diet improves behaviors in a maternal immune activation model of autism spectrum disorder.

Ruskin DN, Murphy MI, Slade SL, Masino SA.

PLoS One. 2017 Feb 6;12(2):e0171643. doi: 10.1371/journal.pone.0171643. eCollection 2017.

13.
14.

Ketogenic diets improve behaviors associated with autism spectrum disorder in a sex-specific manner in the EL mouse.

Ruskin DN, Fortin JA, Bisnauth SN, Masino SA.

Physiol Behav. 2017 Jan 1;168:138-145. doi: 10.1016/j.physbeh.2016.10.023. Epub 2016 Nov 9.

15.

Ketogenic diet prevents epileptogenesis and disease progression in adult mice and rats.

Lusardi TA, Akula KK, Coffman SQ, Ruskin DN, Masino SA, Boison D.

Neuropharmacology. 2015 Dec;99:500-9. doi: 10.1016/j.neuropharm.2015.08.007. Epub 2015 Aug 6.

16.

Effects of a ketogenic diet on hippocampal plasticity in freely moving juvenile rats.

Blaise JH, Ruskin DN, Koranda JL, Masino SA.

Physiol Rep. 2015 May;3(5). pii: e12411. doi: 10.14814/phy2.12411.

17.

Adenosine receptors and epilepsy: current evidence and future potential.

Masino SA, Kawamura M Jr, Ruskin DN.

Int Rev Neurobiol. 2014;119:233-55. doi: 10.1016/B978-0-12-801022-8.00011-8. Review.

18.

Ketogenic diet sensitizes glucose control of hippocampal excitability.

Kawamura M Jr, Ruskin DN, Geiger JD, Boison D, Masino SA.

J Lipid Res. 2014 Nov;55(11):2254-60. doi: 10.1194/jlr.M046755. Epub 2014 Aug 28.

19.

Inchworming: a novel motor stereotypy in the BTBR T+ Itpr3tf/J mouse model of autism.

Smith JD, Rho JM, Masino SA, Mychasiuk R.

J Vis Exp. 2014 Jul 5;(89). doi: 10.3791/50791.

20.

Homeostatic control of brain function - new approaches to understand epileptogenesis.

Boison D, Sandau US, Ruskin DN, Kawamura M Jr, Masino SA.

Front Cell Neurosci. 2013 Jul 16;7:109. doi: 10.3389/fncel.2013.00109. eCollection 2013.

21.

Ketogenic diet improves core symptoms of autism in BTBR mice.

Ruskin DN, Svedova J, Cote JL, Sandau U, Rho JM, Kawamura M Jr, Boison D, Masino SA.

PLoS One. 2013 Jun 5;8(6):e65021. doi: 10.1371/journal.pone.0065021. Print 2013.

22.

Ketogenic diets and pain.

Masino SA, Ruskin DN.

J Child Neurol. 2013 Aug;28(8):993-1001. doi: 10.1177/0883073813487595. Epub 2013 May 16. Review.

23.

Ketogenic diets and thermal pain: dissociation of hypoalgesia, elevated ketones, and lowered glucose in rats.

Ruskin DN, Suter TA, Ross JL, Masino SA.

J Pain. 2013 May;14(5):467-74. doi: 10.1016/j.jpain.2012.12.015. Epub 2013 Mar 15.

24.

Adenosine and autism: a spectrum of opportunities.

Masino SA, Kawamura M Jr, Cote JL, Williams RB, Ruskin DN.

Neuropharmacology. 2013 May;68:116-21. doi: 10.1016/j.neuropharm.2012.08.013. Epub 2012 Aug 24. Review.

25.

Mechanisms of Ketogenic Diet Action.

Masino SA, Rho JM.

In: Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV, editors. Jasper's Basic Mechanisms of the Epilepsies [Internet]. 4th edition. Bethesda (MD): National Center for Biotechnology Information (US); 2012.

26.

Ketone bodies protection against HIV-1 Tat-induced neurotoxicity.

Hui L, Chen X, Bhatt D, Geiger NH, Rosenberger TA, Haughey NJ, Masino SA, Geiger JD.

J Neurochem. 2012 Jul;122(2):382-91. doi: 10.1111/j.1471-4159.2012.07764.x. Epub 2012 May 17.

27.

The nervous system and metabolic dysregulation: emerging evidence converges on ketogenic diet therapy.

Ruskin DN, Masino SA.

Front Neurosci. 2012 Mar 26;6:33. doi: 10.3389/fnins.2012.00033. eCollection 2012.

28.

Purines and neuronal excitability: links to the ketogenic diet.

Masino SA, Kawamura M Jr, Ruskin DN, Geiger JD, Boison D.

Epilepsy Res. 2012 Jul;100(3):229-38. doi: 10.1016/j.eplepsyres.2011.07.014. Epub 2011 Aug 30. Review.

29.

Homeostatic bioenergetic network regulation - a novel concept to avoid pharmacoresistance in epilepsy.

Boison D, Masino SA, Geiger JD.

Expert Opin Drug Discov. 2011 Jul;6(7):713-724.

30.

A ketogenic diet suppresses seizures in mice through adenosine A₁ receptors.

Masino SA, Li T, Theofilas P, Sandau US, Ruskin DN, Fredholm BB, Geiger JD, Aronica E, Boison D.

J Clin Invest. 2011 Jul;121(7):2679-83. doi: 10.1172/JCI57813. Epub 2011 Jun 23.

31.

The relationship between the neuromodulator adenosine and behavioral symptoms of autism.

Masino SA, Kawamura M Jr, Plotkin LM, Svedova J, DiMario FJ Jr, Eigsti IM.

Neurosci Lett. 2011 Aug 1;500(1):1-5. doi: 10.1016/j.neulet.2011.06.007. Epub 2011 Jun 15.

32.

A ketogenic diet reduces long-term potentiation in the dentate gyrus of freely behaving rats.

Koranda JL, Ruskin DN, Masino SA, Blaise JH.

J Neurophysiol. 2011 Aug;106(2):662-6. doi: 10.1152/jn.00001.2011. Epub 2011 May 25.

33.

A ketogenic diet delays weight loss and does not impair working memory or motor function in the R6/2 1J mouse model of Huntington's disease.

Ruskin DN, Ross JL, Kawamura M Jr, Ruiz TL, Geiger JD, Masino SA.

Physiol Behav. 2011 Jul 6;103(5):501-7. doi: 10.1016/j.physbeh.2011.04.001. Epub 2011 Apr 9.

34.

Metabolic autocrine regulation of neurons involves cooperation among pannexin hemichannels, adenosine receptors, and KATP channels.

Kawamura M Jr, Ruskin DN, Masino SA.

J Neurosci. 2010 Mar 17;30(11):3886-95. doi: 10.1523/JNEUROSCI.0055-10.2010.

35.

Adenosine, ketogenic diet and epilepsy: the emerging therapeutic relationship between metabolism and brain activity.

Masino SA, Kawamura M, Wasser CD, Pomeroy LT, Ruskin DN.

Curr Neuropharmacol. 2009 Sep;7(3):257-68. doi: 10.2174/157015909789152164. Erratum in: Curr Neuropharmacol. 2010 Mar;8(1):81. Wasser, C A [corrected to Wasser, C D].

36.

Control of cannabinoid CB1 receptor function on glutamate axon terminals by endogenous adenosine acting at A1 receptors.

Hoffman AF, Laaris N, Kawamura M, Masino SA, Lupica CR.

J Neurosci. 2010 Jan 13;30(2):545-55. doi: 10.1523/JNEUROSCI.4920-09.2010.

37.

Purines and the Anti-Epileptic Actions of Ketogenic Diets.

Masino SA, Kawamura M Jr, Ruskin DN, Gawryluk J, Chen X, Geiger JD.

Open Neurosci J. 2010 Jan 1;4(1):58-63.

38.

Reduced pain and inflammation in juvenile and adult rats fed a ketogenic diet.

Ruskin DN, Kawamura M, Masino SA.

PLoS One. 2009 Dec 23;4(12):e8349. doi: 10.1371/journal.pone.0008349.

39.

Intracellular acidification causes adenosine release during states of hyperexcitability in the hippocampus.

Dulla CG, Frenguelli BG, Staley KJ, Masino SA.

J Neurophysiol. 2009 Sep;102(3):1984-93. doi: 10.1152/jn.90695.2008. Epub 2009 Jul 22.

40.

The ketogenic diet and epilepsy: is adenosine the missing link?

Masino SA, Geiger JD.

Epilepsia. 2009 Feb;50(2):332-3. doi: 10.1111/j.1528-1167.2008.01771.x. No abstract available.

41.

Are purines mediators of the anticonvulsant/neuroprotective effects of ketogenic diets?

Masino SA, Geiger JD.

Trends Neurosci. 2008 Jun;31(6):273-8. doi: 10.1016/j.tins.2008.02.009. Epub 2008 May 9. Review.

42.

Bidirectional synaptic plasticity in the dentate gyrus of the awake freely behaving mouse.

Koranda JL, Masino SA, Blaise JH.

J Neurosci Methods. 2008 Jan 30;167(2):160-6. Epub 2007 Aug 7.

43.

Adenosine and ATP link PCO2 to cortical excitability via pH.

Dulla CG, Dobelis P, Pearson T, Frenguelli BG, Staley KJ, Masino SA.

Neuron. 2005 Dec 22;48(6):1011-23.

44.

Mice lacking the adenosine A1 receptor have normal spatial learning and plasticity in the CA1 region of the hippocampus, but they habituate more slowly.

Giménez-Llort L, Masino SA, Diao L, Fernández-Teruel A, Tobeña A, Halldner L, Fredholm BB.

Synapse. 2005 Jul;57(1):8-16.

45.

Adenosine, glutamate and pH: interactions and implications.

Masino SA, Dulla CG.

Neurol Res. 2005 Mar;27(2):149-52. Review.

PMID:
15829177
46.

Actions of adenosine at its receptors in the CNS: insights from knockouts and drugs.

Fredholm BB, Chen JF, Masino SA, Vaugeois JM.

Annu Rev Pharmacol Toxicol. 2005;45:385-412. Review.

PMID:
15822182
47.
48.

Modulation of hippocampal glutamatergic transmission by ATP is dependent on adenosine a(1) receptors.

Masino SA, Diao L, Illes P, Zahniser NR, Larson GA, Johansson B, Fredholm BB, Dunwiddie TV.

J Pharmacol Exp Ther. 2002 Oct;303(1):356-63.

PMID:
12235271
49.

Vitamin B6 therapy during childbearing years: cause for caution?

Masino SA, Kahle JS.

Nutr Neurosci. 2002 Sep;5(4):241-2.

PMID:
12168686
50.

Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor.

Johansson B, Halldner L, Dunwiddie TV, Masino SA, Poelchen W, Giménez-Llort L, Escorihuela RM, Fernández-Teruel A, Wiesenfeld-Hallin Z, Xu XJ, Hårdemark A, Betsholtz C, Herlenius E, Fredholm BB.

Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):9407-12. Epub 2001 Jul 24.

Supplemental Content

Loading ...
Support Center